How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
3D CBCT Machine Market
- By Application: Dental Implantology, Orthodontics, Endodontics, Oral and Maxillofacial Surgery, ENT (Ear, Nose, Throat) Imaging
- By Product Type: Fixed CBCT Systems, Mobile CBCT Systems, Desktop CBCT Systems
- By End User: Dental Clinics, Hospitals, Diagnostic Imaging Centers, Research and Academic Institutes
- By Technology: Flat Panel Detector CBCT, Image Intensifier CBCT
- By Field of View (FOV) Size: Small FOV (up to 5 cm), Medium FOV (5-10 cm), Large FOV (above 10 cm)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Dental Implantology leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 287 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.173 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.181 →
Full report · locked preview
Everything inside the 3D CBCT Machine Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Application 5
Product Type 3
End User 4
Technology 2
Field of View (FOV) Size 3
Companies profiled
Planmeca Oy
Carestream Health (a division of Onex Corporation)
Sirona Dental Systems (a part of Dentsply Sirona)
Vatech Co. Ltd.
NewTom (Quantitative Radiology)
Morita Corporation
J. Morita USA Inc.
KaVo Kerr
MyRay (a division of Cefla Group)
Soredex (a part of Dürr Dental)
Ray Co. Ltd.
Instrumentarium Dental (a part of KaVo Kerr)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Planmeca Oy
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Carestream Health (a division of Onex Corporation)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sirona Dental Systems (a part of Dentsply Sirona)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Vatech Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →NewTom (Quantitative Radiology)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Morita Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →J. Morita USA Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →KaVo Kerr
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →MyRay (a division of Cefla Group)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Soredex (a part of Dürr Dental)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Ray Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Instrumentarium Dental (a part of KaVo Kerr)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Dentsply Sirona
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →3Shape
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Acteon Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,537M by 2033 · 9.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Dental Implantology52.7
- Orthodontics14.2
- Endodontics6.3
- Oral and Maxillofacial Surgery15.3
- ENT (Ear, Nose, Throat) Imaging11.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$252.5M → $515.1M · 9.3%
Europe$176.0M → $320.8M · 7.8%
Asia Pacific$160.7M → $353.0M · 10.3%
Latin America$99.5M → $188.1M · 8.3%
Middle East and Africa$76.5M → $159.1M · 9.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.072026
9.082027
9.082028
9.092029
9.122030
9.122031
9.142032
9.152033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Planmeca Oy9.8
- Carestream Health (a division of Onex Corporation)16.0
- Sirona Dental Systems (a part of Dentsply Sirona)11.8
- Vatech Co. Ltd.9.5
- NewTom (Quantitative Radiology)11.1
- Morita Corporation13.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Application21.5%
Product Type19.2%
End User11.6%
Technology25.3%
Field of View (FOV) Size22.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.5
- Europe20.9
- Asia Pacific23.0
- Latin America12.2
- Middle East and Africa10.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Planmeca Oy | 73 | 84 | 86 | 81 | 81 | 89 | 82 |
| Carestream Health (a division of Onex Corporation) | 92 | 81 | 92 | 70 | 74 | 77 | 81 |
| Sirona Dental Systems (a part of Dentsply Sirona) | 62 | 67 | 78 | 78 | 67 | 77 | 72 |
| Vatech Co. Ltd. | 80 | 80 | 68 | 74 | 77 | 61 | 73 |
| NewTom (Quantitative Radiology) | 71 | 53 | 64 | 64 | 70 | 63 | 64 |
| Morita Corporation | 61 | 65 | 68 | 61 | 65 | 50 | 62 |
| J. Morita USA Inc. | 50 | 61 | 45 | 44 | 52 | 62 | 52 |
| KaVo Kerr | 47 | 49 | 58 | 58 | 57 | 55 | 54 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Planmeca Oy
- Carestream Health (a division of Onex Corporation)
- Sirona Dental Systems (a part of Dentsply Sirona)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Planmeca Oy | ✓ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Carestream Health (a division of Onex Corporation) | ◐ | ◐ | ✓ | ◐ | ✓ | ◐ |
| Sirona Dental Systems (a part of Dentsply Sirona) | ✓ | ◐ | ✓ | ✓ | − | ✓ |
| Vatech Co. Ltd. | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| NewTom (Quantitative Radiology) | ✓ | ◐ | ◐ | − | − | ◐ |
| Morita Corporation | − | − | ◐ | − | ◐ | − |
| J. Morita USA Inc. | ◐ | ◐ | − | − | − | ◐ |
| KaVo Kerr | − | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Planmeca Oy82
2Carestream Health (a division of Onex Corporation)81
3Vatech Co. Ltd.73
4Sirona Dental Systems (a part of Dentsply Sirona)72
5NewTom (Quantitative Radiology)64
6Morita Corporation62
7KaVo Kerr54
8J. Morita USA Inc.52
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Planmeca OyCarestream Health (a division of Onex Corporation)
Challenger2
Strong scale, closing on the leaders.
Sirona Dental Systems (a part of Dentsply Sirona)Vatech Co. Ltd.
Contender2
Focused players with pockets of strength.
NewTom (Quantitative Radiology)Morita Corporation
Niche2
Specialists in a single segment or region.
J. Morita USA Inc.KaVo Kerr
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across 3D CBCT Machine Market — a $423M beachhead inside a $6.56B market.
Beachhead (SOM)$423Mobtainable near-term
Serviceable (SAM)$2.32Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Dental Implantology
Best fit — highest urgency & budget in Application.
Economic buyer76 fit
Orthodontics
Strong fit — clear ROI and a fast path to value.
End user65 fit
Endodontics
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Product Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel26%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win 3D CBCT Machine Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified25%
Evaluation14%
Closed-won6%
$11.0KCAC
$55KLTV
5.0:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
3D CBCT Machine Market is a resilient opportunity — $7.44B by 2033, compounding at 6.0%.
TAM · 2025$4.67Btoday
TAM · 2033$7.44Bforecast
CAGR6.0%2027–2033
Cumulative$53.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.44BTotal addressable market
SAM$2.53BServiceable available market
SOM$481MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.0% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.44BLarge & growingTAM by 2033 at 6.0% CAGR
$2.53BServiceable nowreachable with today’s model
$481MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.80BBear3.9% CAGR
$7.44BBase6.0% CAGR
$9.53BBull7.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Product Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
3D CBCT Machine Market — a $3.63B market by 2033. Plan: grow share from 7.7% to 16.2%.
Market size · 2033$3.63Btotal addressable
Market CAGR8.9%2027–2033
Target share16.2%from 7.7% today
Revenue ambition$588Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.7% | 16.2% | Behind |
| Revenue | $264M | $588M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 37.4% | 43.1% | On track |
| Customer retention | 86.7% | 96.8% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Product Type capability
A defensible second engine — invest in Product Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Product Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $66M capacity & capability investment
- Greenlight bolt-on M&A in Product Type
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the 3D CBCT Machine Market conversation — a $6.90B market you can size, segment and defend in minutes.
Market size · 2033$6.90Btotal opportunity
Growth5.6%CAGR to 2033
Addressable buyers967+accounts in scope
Typical ROI6.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.2×return on cost, year one
< 3 mopayback period
$83K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Planmeca OyCarestream Health (a division of Onex Corporation)Sirona Dental Systems (a part of Dentsply Sirona)Vatech Co. Ltd.NewTom (Quantitative Radiology)Morita CorporationJ. Morita USA Inc.KaVo Kerr+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your 3D CBCT Machine Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
3D CBCT Machine Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →3D Cardiac Imaging Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View report3D Cardiac EP Mapping Systems Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View report3D Cardiac Electrophysiology Equipment Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportePRO, E-Patient Diaries and eCOA Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportEMS-ODM Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View report3D Body Scanners Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportDrug Discovery Assays Market
Market size, share, segmentation and regional forecast.
$938M market · 2025 base year
View report3D Body Holographic (Millimeter Wave) Scanner Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View report3D Bioprocess Bags Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View report3D Bioprinting Material Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View report3D Bioprinting for Tissue and Organ Regeneration Market
Market size, share, segmentation and regional forecast.
$684M market · 2025 base year
View reportDistance Health Technologies Market
Market size, share, segmentation and regional forecast.
$440M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.